Safety and effectiveness of biphasic insulin aspart 30 in people with type 2 diabetes switching from basal-bolus insulin regimens in the A1chieve study

Bolus Insulin ◽

Basal Bolus

Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy

Clinical Therapeutics ◽

10.1016/s0149-2918(03)90095-6 ◽

2003 ◽

Vol 25 (12) ◽

pp. 3109-3123 ◽

Cited By ~ 17

Author(s):

Itamar Raz ◽

Ulrik Mouritzen ◽

Julius Vaz ◽

Tommy Hershkovitz ◽

Julio Wainstein ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING

Value in Health ◽

10.1016/s1098-3015(10)75002-6 ◽

2009 ◽

Vol 12 (7) ◽

pp. A405-A406

Author(s):

E Suchankova ◽

T Doležal ◽

Z Pisarikova ◽

K Rychna ◽

D Bartaskova

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Cost Effectiveness Analysis ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Effectiveness Analysis ◽

Biphasic Insulin Aspart 30 Three Times Daily Is More Effective Than a Twice-Daily Regimen, Without Increasing Hypoglycemia, in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Drugs

Diabetes Care ◽

10.2337/dc07-1992 ◽

2008 ◽

Vol 31 (5) ◽

pp. 852-856 ◽

Cited By ~ 26

Author(s):

W. Yang ◽

Q. Ji ◽

D. Zhu ◽

J. Yang ◽

L. Chen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Daily Regimen ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Oral Antidiabetes Drugs ◽

Chinese Subjects

Similar glucose control with basal–bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification

Diabetes & Metabolism ◽

10.1016/j.diabet.2014.11.002 ◽

2015 ◽

Vol 41 (3) ◽

pp. 223-230 ◽

Cited By ~ 8

Author(s):

R. Malek ◽

F. Ajili ◽

S.H. Assaad-Khalil ◽

A. Shinde ◽

J.W. Chen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Aspart ◽

Glucose Control ◽

Insulin Detemir ◽

Insulin Intensification ◽

Biphasic Insulin ◽

Basal Bolus

PDB5 GLYCAEMIC CONTROL AND INSULIN UTILIZATION IN UK PATIENTS WITH TYPE 2 DIABETES INITIATED ON EITHER BIPHASIC INSULIN ASPART 30 OR BIPHASIC HUMAN INSULIN 30

Value in Health ◽

10.1016/s1098-3015(10)72252-x ◽

2010 ◽

Vol 13 (3) ◽

pp. A55 ◽

Cited By ~ 1

Author(s):

W Fakhoury ◽

H Richter ◽

T Christensen ◽

TL Thomsen ◽

D Irwin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Comparison of Insulin Degludec/Insulin Aspart and Biphasic Insulin Aspart 30 in Uncontrolled, Insulin-Treated Type 2 Diabetes: A Phase 3a, Randomized, Treat-to-Target Trial

Diabetes Care ◽

10.2337/dc13-2908 ◽

2014 ◽

Vol 37 (8) ◽

pp. 2084-2090 ◽

Cited By ~ 59

Author(s):

Gregory R. Fulcher ◽

Jens Sandahl Christiansen ◽

Ganapathi Bantwal ◽

Miroslawa Polaszewska-Muszynska ◽

Henriette Mersebach ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Insulin Degludec ◽

Treat To Target ◽

Target Trial ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic insulin aspart 30 treatment in patients with type 2 diabetes poorly controlled on prior diabetes treatment: results from the PRESENT study

Current Medical Research and Opinion ◽

10.1185/030079908x260952 ◽

2008 ◽

Vol 24 (3) ◽

pp. 645-652 ◽

Cited By ~ 16

Author(s):

S. K. Sharma ◽

M. Al-Mustafa ◽

S. J. Oh ◽

S. T. Azar ◽

M. Shestakova ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Diabetes Treatment ◽

Treatment Results ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts)

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2007.00796.x ◽

2009 ◽

Vol 11 (1) ◽

pp. 27-32 ◽

Cited By ~ 24

Author(s):

P. Raskin ◽

G. Matfin ◽

S. L. Schwartz ◽

L. Chaykin ◽

P.-L. Chu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Oral Agents ◽

Pioglitazone Treatment

A double-blind, randomised, crossover study to investigate the difference in frequency of episodes of hypoglycaemia during treatment with Biphasic Insulin Aspart 30 (NovoMix®30) compared to Biphasic Human Insulin 30 (Mixtard® 30) in patients with well-controlled, type 2 diabetes

http://isrctn.org/> ◽

10.1186/isrctn34091554 ◽

2013 ◽

Author(s):

Paul McNally

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Human Insulin ◽

Insulin Aspart ◽

Double Blind ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

The Difference

Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia

Journal of Medical Economics ◽

10.3111/13696990802589122 ◽

2008 ◽

Vol 11 (4) ◽

pp. 651-670 ◽

Cited By ~ 11

Author(s):

Mohammed Ali ◽

Jeremy White ◽

Chen-Hui Lee ◽

James L Palmer ◽

Jayne Smith-Palmer ◽

...

Keyword(s):

Type 2 Diabetes ◽

Saudi Arabia ◽

Insulin Aspart ◽

Long Term Outcomes ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽